How Phosphodiesterase 4 Inhibitors Work in Patients with Chronic Obstructive Pulmonary Disease of the Severe, Bronchitic, Frequent Exacerbator Phenotype-Reference-Cited by-同舟云学术

How Phosphodiesterase 4 Inhibitors Work in Patients with Chronic Obstructive Pulmonary Disease of the Severe, Bronchitic, Frequent Exacerbator Phenotype

Published:2014-03 Issue:1 Volume:35 Page:203-217
ISSN:0272-5231
Container-title:Clinics in Chest Medicine
language:en
Short-container-title:Clinics in Chest Medicine

Author:

Giembycz Mark A.,Newton Robert

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine

Reference138 articles.

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary;Pauwels;Am J Respir Crit Care Med,2001

2. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease;Hogg;Lancet,2004

3. The nature of small-airway obstruction in chronic obstructive pulmonary disease;Hogg;N Engl J Med,2004

4. Respiratory health effects of air pollution: update on biomass smoke and traffic pollution;Laumbach;J Allergy Clin Immunol,2012

5. Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease;Walter;Environ Health Perspect,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease;Frontiers in Pharmacology;2021-11-23

2. Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury;Journal of Investigative Surgery;2021-04-11

3. Prostanoid Receptors of the EP4-Subtype Mediate Gene Expression Changes in Human Airway Epithelial Cells with Potential Anti-Inflammatory Activity;Journal of Pharmacology and Experimental Therapeutics;2020-11-06

4. Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease;The Korean Journal of Internal Medicine;2020-03-01

5. Impact of Phosphodiesterase 4 Inhibition on the Operational Efficacy, Response Maxima, and Kinetics of Indacaterol-Induced Gene Expression Changes in BEAS-2B Airway Epithelial Cells: A Global Transcriptomic Analysis;Molecular Pharmacology;2019-04-29